South Africa: Competition Commission victory for Aids activists

"A few weeks ago the government revealed its operational ARV treatment plan. Now we celebrate five years of constant struggle with the announcement of a great victory for people living with HIV/AIDS and for public health - a momentous settlement agreement reached at the South African Competition Commission between pharmaceutical companies and AIDS activists. The Treatment Action Campaign (TAC), COSATU, CEPPWAWU, the AIDS Consortium, four people living with HIV/AIDS and four health-care workers have entered into settlement agreements with pharmaceutical giants GlaxoSmithKline (GSK) and Boehringer Ingelheim (BI). In signing these agreements, AIDS activists have now concluded their complaint against GSK and BI. The terms of the agreements go well beyond what could conceivably have been won by pursuing the prosecution of the complaint under the Competition Act."
Background Link:
Companies To Allow Generic HIV/AIDS Drugs In South Africa